Interactive Financial Charts Not Available

Procter & Gamble (PGHL) | Financial Analysis & Statements

Procter & Gamble Health Ltd. | Mid-cap | Healthcare

₹6,295.00

1.82%

Procter & Gamble vs Sun Pharmaceutical Procter & Gamble vs Divi's Laboratories Procter & Gamble vs Alembic Procter & Gamble vs Jubilant Pharmova Procter & Gamble vs Neuland Laboratories Procter & Gamble vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 3.4B

Gross Profit 2.4B 72.25%

Operating Income 849.0M 25.06%

Net Income 661.8M 19.54%

EPS (Diluted) ₹39.87

Balance Sheet Metrics

Total Assets 7.9B

Total Liabilities 2.6B

Shareholders Equity 5.4B

Debt to Equity 0.48

Cash Flow Metrics

Operating Cash Flow 711.0M

Free Cash Flow 459.9M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Procter & Gamble Income Statement From 2018 to 2024

Metric	2024	2023	2022	2021	2018
Revenue i	11.3B	12.3B	11.1B	9.9B	8.2B
Cost of Goods Sold i	3.6B	3.6B	3.4B	3.4B	2.9B
Gross Profit i	7.7B	8.7B	7.7B	6.5B	5.3B
Gross Margin % i	68.2%	70.6%	69.5%	66.0%	65.2%
Operating Expenses
Research & Development i	38.6M	-	65.5M	39.3M	20.5M
Selling, General & Administrative i	876.3M	-	1.5B	1.3B	1.2B
Other Operating Expenses i	1.8B	3.4B	3.4B	1.3B	1.5B
Total Operating Expenses i	2.7B	3.4B	4.9B	2.7B	2.8B
Operating Income i	2.8B	3.0B	2.4B	2.3B	1.3B
Operating Margin % i	24.7%	24.1%	21.7%	22.7%	15.6%
Non-Operating Items
Interest Income i	117.3M	-	110.7M	150.6M	171.9M
Interest Expense i	7.2M	7.7M	4.2M	8.0M	-
Other Non-Operating Income	-	-	-	-	-
Pre-tax Income i	2.7B	3.1B	2.5B	2.3B	1.6B
Income Tax i	723.4M	847.3M	608.5M	564.8M	562.4M
Effective Tax Rate % i	26.5%	27.0%	24.0%	24.2%	35.6%
Net Income i	2.0B	2.3B	1.9B	1.8B	8.4B
Net Margin % i	17.8%	18.7%	17.3%	17.8%	102.5%
Key Metrics
EBITDA i	3.2B	3.4B	2.8B	2.7B	1.5B
EPS (Basic) i	₹121.00	₹138.23	₹115.98	₹107.00	₹505.00
EPS (Diluted) i	₹121.00	₹138.23	₹115.98	₹107.00	₹505.00
Basic Shares Outstanding i	16599382	16600593	16599414	16599382	16599382
Diluted Shares Outstanding i	16599382	16600593	16599414	16599382	16599382

Income Statement Trend

Procter & Gamble Balance Sheet From 2018 to 2024

Metric	2024	2023	2022	2021	2018
Assets
Current Assets
Cash & Equivalents i	2.4B	4.4B	3.2B	4.6B	11.2B
Short-term Investments i	192.3M	177.3M	125.9M	108.4M	1.2B
Accounts Receivable i	853.3M	1.2B	834.4M	598.1M	661.7M
Inventory i	1.1B	1.3B	1.2B	1.2B	1.1B
Other Current Assets	613.3M	911.4M	746.7M	730.0M	851.3M
Total Current Assets i	5.2B	8.0B	6.1B	7.3B	15.3B
Non-Current Assets
Property, Plant & Equipment i	1.3B	1.4B	1.1B	1.0B	0
Goodwill i	9.6M	9.4M	400.0K	1.2M	4.3M
Intangible Assets i	9.6M	-	400.0K	1.2M	4.3M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	18.9M	93.0M	-6.9M	-96.0M	-100.0K
Total Non-Current Assets i	2.7B	3.1B	2.8B	2.6B	2.3B
Total Assets i	7.9B	11.0B	8.9B	9.9B	17.6B
Liabilities
Current Liabilities
Accounts Payable i	1.7B	2.4B	1.8B	1.8B	914.2M
Short-term Debt i	26.8M	31.2M	28.3M	47.5M	65.3M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	125.3M	89.2M	92.4M	82.4M	1.9M
Total Current Liabilities i	2.2B	3.0B	2.4B	2.4B	1.9B
Non-Current Liabilities
Long-term Debt i	68.8M	88.8M	0	28.6M	-
Deferred Tax Liabilities i	-	-	-	-	87.4M
Other Non-Current Liabilities	6.9M	6.5M	6.0M	5.7M	28.5M
Total Non-Current Liabilities i	372.1M	464.0M	414.0M	434.8M	265.4M
Total Liabilities i	2.6B	3.5B	2.8B	2.8B	2.2B
Equity
Common Stock i	166.0M	166.0M	166.0M	166.0M	166.0M
Retained Earnings i	1.6B	-	2.4B	3.3B	11.7B
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	5.4B	7.5B	6.2B	7.0B	15.4B
Key Metrics
Total Debt i	95.6M	120.0M	28.3M	76.1M	65.3M
Working Capital i	3.1B	4.9B	3.8B	4.9B	13.4B

Balance Sheet Composition

Procter & Gamble Cash Flow Statement From 2018 to 2024

Metric	2024	2023	2022	2021	2018
Operating Activities
Net Income i	2.7B	3.1B	2.5B	2.3B	11.4B
Depreciation & Amortization i	-	-	-	-	-
Stock-Based Compensation i	6.9M	5.6M	34.1M	19.3M	-
Working Capital Changes i	594.9M	-939.4M	-408.0M	394.1M	-771.8M
Operating Cash Flow i	3.2B	2.1B	2.0B	2.6B	10.4B
Investing Activities
Capital Expenditures i	-217.3M	-424.8M	-379.2M	-525.8M	-265.4M
Acquisitions i	-	-	-	-	10.5B
Investment Purchases i	-	-	-	-	-1.8B
Investment Sales i	-	-	-	0	3.9B
Investing Cash Flow i	-194.9M	-356.9M	-354.2M	-493.5M	12.5B
Financing Activities
Share Repurchases i	-	-	-	-	-
Dividends Paid i	-4.1B	-937.9M	-2.8B	-3.8B	-249.7M
Debt Issuance i	-	-	-	-	-
Debt Repayment i	-	-	-	-	-
Financing Cash Flow i	-4.1B	-937.9M	-2.8B	-3.8B	-301.2M
Free Cash Flow i	2.1B	1.9B	1.3B	1.9B	-1.6B
Net Change in Cash i	-1.1B	757.3M	-1.2B	-1.7B	22.6B

Cash Flow Trend

Procter & Gamble Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 57.14

Price to Book 19.56

Price to Sales 8.64

PEG Ratio -4.58

Profitability Ratios

Profit Margin 20.62%

Operating Margin 25.06%

Return on Equity 37.41%

Return on Assets 25.30%

Financial Health

Current Ratio 2.44

Debt to Equity 0.01

Beta 0.43

Per Share Data

EPS (TTM) ₹111.00

Book Value per Share ₹324.25

Revenue per Share ₹733.80

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
pghl	105.3B	57.14	19.56	37.41%	20.62%	0.01
Sun Pharmaceutical	3.9T	37.88	5.45	15.08%	19.29%	3.26
Divi's Laboratories	1.6T	70.42	10.88	14.64%	23.89%	0.03
Alembic	188.4B	31.15	3.62	11.24%	8.84%	24.23
Jubilant Pharmova	167.3B	36.50	2.67	13.45%	6.22%	43.78
Neuland Laboratories	170.4B	97.09	11.17	17.06%	13.24%	10.31

Financial data is updated regularly. All figures are in the company's reporting currency.